Join us on Tuesday, September 1, to learn about why patients are admitted to an intensive care unit and what is available in terms of physiological support, monitoring, and treatments
Learn about the potential of lateral flow assays in detecting symptomatic and asymptomatic COVID-19 infections
The partnership enables LUMICKS to expand on the implementation of the z-Movi to new immunotherapeutic settings
Trial supports Abbott's focus on being the best partner for electrophysiologists treating people living with atrial fibrillation
Exclusive interviews, new methods, free downloads, and much more to help you advance your work
87 percent of patients in ZUMA-2 pivotal trial responded to single infusion of Tecartus
The study is the first global, randomized, double-blind, placebo-controlled phase III trial investigating Actemra/RoActemra in this setting
The ViroKey™ SARS-CoV-2 RT-PCR Test v2.0 is a probe-based reverse transcription PCR test
The NeuroSphere Digital Care offers flexible virtual care options as the COVID-19 global pandemic impacts how healthcare is administered
Based on the results, the U.S.-based trial has been stopped, including in a second cohort of patients who received a higher dose of Kevzara (800 mg)
A new test being developed by Iceni Diagnostics promises a quick way to distinguish between the two diseases
Delivers major improvements for discoveries in immunology, oncology, autoimmunity, and infectious diseases
Patented PrimeStore MTM technology is designed to enable safe sample handling and testing for multiple pathogens from one sample swab
Collaboration combines innovative plant-based and adjuvant technologies to develop and produce a COVID-19 candidate vaccine
This is the company's third diagnostic test to receive Emergency Use Authorization by U.S. FDA for detecting COVID-19
Gallant ICD and CRT-D devices feature a patient-preferred design without compromising on battery longevity and compatibility with magnetic resonance imaging (MRI)
Prof. Ishii explains how high-sensitivity troponin I assays and a 1-hour algorithm can be best used for early diagnosis and treatment of myocardial infarction
binx health’s proven molecular io platform combined with SHERLOCK CRISPR technology will enable rapid, accurate testing for SARS-CoV-2 in retail and near-patient settings
